We report five cases of spider angiomas in children treated topically with timolol 0.5% (ophthalmic solution or gel-forming solution), for 6 months. Parents and patients were advised to apply one drop twice daily. Four of them showed either partial (2) or complete response (2) and only one patient had no clinical change. No adverse effects were reported. This pilot case series shows that topical timolol may prove useful as a noninvasive, available and well-tolerated treatment option for spider angiomas in children who seek a treatment alternative to pulsed dye laser.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/pde.15788 | DOI Listing |
Pediatr Dermatol
October 2024
Department of Dermatology, Children's Hospital, Philadelphia, Pennsylvania, USA.
We report five cases of spider angiomas in children treated topically with timolol 0.5% (ophthalmic solution or gel-forming solution), for 6 months. Parents and patients were advised to apply one drop twice daily.
View Article and Find Full Text PDFRadiol Case Rep
December 2024
Department of Internal Medicine, Las Palmas Del Sol Medical Center, El Paso, TX, USA.
Oxf Med Case Reports
February 2024
Department of Dermatology, Alassad Medical Centre, Hama, Syrian Arab Republic.
Spider angioma is a cutaneous nevus caused by a vascular abnormality, characterized by a central red area with radiating reddish, web-like extensions. It is typically associated with liver cirrhosis, hyperestrogenism, and alcohol consumption. In this case report, we present a unique instance of a patient who developed spider angioma at the injection site of the meningitis vaccine as a long-term adverse effect.
View Article and Find Full Text PDFJ Clin Exp Hepatol
December 2023
Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Spider angiomas are dilated vascular channels in the skin. They have a central arteriole with surrounding vascular channels resembling legs of a spider, hence the name. They are frequently associated with liver cirrhosis, thyrotoxicosis, and pregnancy.
View Article and Find Full Text PDFBackground: Patients frequently seek laser treatment for vascular conditions. More recently, a novel 532 and 1,064 nm laser was developed to offer greater flexibility.
Objective: A prospective clinical trial evaluated the safety and efficacy of a novel, variable-sequenced, long-pulsed, 532 and 1,064 nm laser with cryogen spray cooling (DermaV, Lutronic, South Korea).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!